WEBULL
News
ASRT
12.74
+9.64%
1.12
Weekly Report: what happened at ASRT last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at ASRT last week (0119-0123)?
Weekly Report · 01/26 10:25
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Agenus (AGEN) and Assertio Therapeutics (ASRT)
TipRanks · 01/21 15:30
Weekly Report: what happened at ASRT last week (0112-0116)?
Weekly Report · 01/19 10:31
Mid to low cap healthcare stocks with the strongest earnings momentum
Seeking Alpha · 01/16 19:42
Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet
NASDAQ · 01/16 14:55
Assertio regains Nasdaq compliance after bid price recovery
Seeking Alpha · 01/12 21:22
Assertio regains compliance with Nasdaq listing requirements
TipRanks · 01/12 21:21
ASSERTIO HOLDINGS, INC. REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS
Reuters · 01/12 21:15
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
Barchart · 01/12 15:15
Weekly Report: what happened at ASRT last week (0105-0109)?
Weekly Report · 01/12 10:30
Assertio Data From Clinical Study Of Rolvedon Injection Demonstrates Effective Neutrophil Recovery
Benzinga · 01/09 18:50
Assertio Publishes Study Showing Rolvedon Safe and Effective for Same-Day Dosing with TC Chemotherapy
Reuters · 01/09 18:45
ASSERTIO ANNOUNCES PUBLICATION OF ROLVEDON® SAME-DAY DOSING CLINICAL TRIAL
Reuters · 01/09 18:45
Assertio Holdings Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 01/05 12:33
Assertio Holdings Price Target Raised to $35.00/Share From $3.00 by HC Wainwright & Co.
Dow Jones · 01/05 12:33
HC Wainwright & Co. Maintains Buy on Assertio Holdings, Raises Price Target to $35
Benzinga · 01/05 12:23
ASSERTIO HOLDINGS INC <ASRT.O>: H.C. WAINWRIGHT ADJUSTS TARGET PRICE TO $35 FROM $3 TO REFLECT 1-FOR-15 REVERSE STOCK SPLIT
Reuters · 01/05 11:42
Assertio price target adjusted to $35 from $3 at H.C. Wainwright
TipRanks · 01/05 11:10
Weekly Report: what happened at ASRT last week (1229-0102)?
Weekly Report · 01/05 10:24
More
Webull provides a variety of real-time ASRT stock news. You can receive the latest news about Assertio Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About ASRT
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.